FR3000404B1 - Composition dermatologique comprenant un inhibiteur de pde7 sous forme dispersee, son procede de preparation et son utilisation - Google Patents

Composition dermatologique comprenant un inhibiteur de pde7 sous forme dispersee, son procede de preparation et son utilisation

Info

Publication number
FR3000404B1
FR3000404B1 FR1262926A FR1262926A FR3000404B1 FR 3000404 B1 FR3000404 B1 FR 3000404B1 FR 1262926 A FR1262926 A FR 1262926A FR 1262926 A FR1262926 A FR 1262926A FR 3000404 B1 FR3000404 B1 FR 3000404B1
Authority
FR
France
Prior art keywords
dispersee
preparation
dermatological composition
pde7 inhibitor
pde7
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1262926A
Other languages
English (en)
Other versions
FR3000404A1 (fr
Inventor
Caroline Glazal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR1262926A priority Critical patent/FR3000404B1/fr
Priority to PCT/FR2013/053242 priority patent/WO2014102498A1/fr
Publication of FR3000404A1 publication Critical patent/FR3000404A1/fr
Application granted granted Critical
Publication of FR3000404B1 publication Critical patent/FR3000404B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1262926A 2012-12-28 2012-12-28 Composition dermatologique comprenant un inhibiteur de pde7 sous forme dispersee, son procede de preparation et son utilisation Expired - Fee Related FR3000404B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1262926A FR3000404B1 (fr) 2012-12-28 2012-12-28 Composition dermatologique comprenant un inhibiteur de pde7 sous forme dispersee, son procede de preparation et son utilisation
PCT/FR2013/053242 WO2014102498A1 (fr) 2012-12-28 2013-12-20 Composition dermatologique comprenant un inhibiteur de pde7 sous forme dispersée, son procédé de préparation et son utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1262926A FR3000404B1 (fr) 2012-12-28 2012-12-28 Composition dermatologique comprenant un inhibiteur de pde7 sous forme dispersee, son procede de preparation et son utilisation

Publications (2)

Publication Number Publication Date
FR3000404A1 FR3000404A1 (fr) 2014-07-04
FR3000404B1 true FR3000404B1 (fr) 2015-02-06

Family

ID=47989194

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1262926A Expired - Fee Related FR3000404B1 (fr) 2012-12-28 2012-12-28 Composition dermatologique comprenant un inhibiteur de pde7 sous forme dispersee, son procede de preparation et son utilisation

Country Status (2)

Country Link
FR (1) FR3000404B1 (fr)
WO (1) WO2014102498A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007000214A (es) * 2004-07-01 2007-05-10 Asubio Pharma Co Ltd Derivado de tienopirazol que tiene actividad inhibidora de pde 7.
US8637528B2 (en) * 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders

Also Published As

Publication number Publication date
WO2014102498A1 (fr) 2014-07-03
FR3000404A1 (fr) 2014-07-04

Similar Documents

Publication Publication Date Title
BR112015002541A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente.
SG11201406085TA (en) Method and system for operating winches, and use thereof
ZA201501541B (en) Supported catalyst and active form thereof, and preparation method and use thereof
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
PL2713718T3 (pl) Płynny preparat do biologicznej ochrony roślin, sposób jego wytwarzania i jego zastosowanie
BR112013010725A2 (pt) método, e, composição
BR112012031232A2 (pt) método, dispositivo e uso
ZA201503753B (en) Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
ITMI20111404A1 (it) Supporto per articolazioni umane.
BR112012016424A2 (pt) aparelho, e método.
BR112014026149A2 (pt) método para a preparação de 2,4-ácido dihidroxibutírico (2,4-dhb) e microrganismo.
EP2639215A4 (fr) Sels de kukoamine b, procédé de préparation et utilisation
FR2959733B1 (fr) Grue et procede de relevage de la grue.
FR2986795B1 (fr) Composition cosmetique comprenant un compose multifonctionnel, compose et procede de traitement cosmetique
BR112014026873A2 (pt) método cosmético, composição cosmética e uso.
BR112014029259A2 (pt) método, aparelho e produto eletrolítico
EP2868260A4 (fr) Dispositif de support de gestion de la santé procédé et programme
BR112015015040A2 (pt) composição sólida ou semissólida, método para a preparação da composição e utilização da composição
FR2997848B1 (fr) Composition comprenant un derive dicarbonyle et procede de lissage des cheveux a partir de cette composition
EP2937541A4 (fr) Engin de mesure, système de mesure et procédé de mesure
FR2950253B1 (fr) Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
PL2928861T3 (pl) Pochodne aminocyklobutanu, sposób ich wytwarzania i ich zastosowanie jako leki
EP2687532A4 (fr) Nouveau dérivé octahydrothiénoquinoline, composition pharmaceutique comprenant le dérivé, et utilisation de ceux-ci
EP2858561A4 (fr) Dispositif, procédé et logiciel pour mesurer la capacité expiratoire
EP2868689A4 (fr) Procédé de préparation d'un film électrolyte sous forme de gel polyacrylonitrile-méthacrylate de méthyle correspondant et procédé de préparation approprié

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160831